Essilor : 2013 Registration Document Filed

  Essilor : 2013 Registration Document Filed  Business Wire  CHARENTON-LE-PONT, France -- March 26, 2014  Regulatory News:  Essilor (Paris:EI):  The 2013 Essilor Registration Document was filed in French version with the Autorité des Marchés Financiers (AMF) on March 25, 2014 under the number D.14-0200. The Registration Document includes:  a) The Annual Financial Report, with:    *The parent company financial statements;   *The consolidated financial statements;   *A management report containing information in compliance with articles     L.225-100, L.225-100-3, L.225-11 (§ 2) and L.225-100-2 of the French     Commercial Code;   *A statement by the persons responsible for the Registration Document;   *The report of the Auditors on the parent company and consolidated     financial statements;   *Information concerning Auditors’ fees.  b) The Chairman’s report on corporate governance and internal control.  c) The description of the share buyback program.  From now on, the French version is available to the public free of charge, as provided for in applicable legislation, and may be viewed on Essilor’s corporate website www.essilor.com.  The English version will be available on the website from April 2, 2014.  About Essilor The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates more than €150 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilor’s flagship brands are Varilux^®, Crizal^®, Definity^®, Xperio^®, Optifog^TM, Foster Grant^®, Bolon^® and Costa^®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of over €5 billion in 2013 and employs more than 55,000 people. It operates in some 100 countries with 28 plants, more than 450 prescription laboratories and edging facilities, as well as several research and development centers around the world. For more information, please visit www.essilor.com. The Essilor share trades on the NYSE Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.  Contact:  Essilor Investor Relations and Financial Communications Phone: +33 (0)1 49 77 42 16  
Press spacebar to pause and continue. Press esc to stop.